News
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
Novavax shows financial improvement but faces vaccine challenges. Read why I rated NVAX stock as 'Hold' and what risks and ...
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...
Novavax’s protein-based vaccine is only available under a pandemic-era emergency-use authorization, and formal approval from ...
HHS Secretary Robert F. Kennedy Jr. is mulling removing the Covid-19 vaccine from the recommended childhood vaccine schedule.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results